Who invested in Agios Pharmaceuticals?
Agios Pharmaceuticals's investors include ARCH Venture Partners, Third Rock Ventures, Flagship Pioneering, LLC, Flagship Ventures and Celgene.
United States · Series C startup
4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$120Mraised across 4 rounds since 2008, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $78M sold, first sale Nov 2011
No investor was named in the report.
Reported by sec.govSEC filing: $8.8M sold, first sale Apr 2010
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Agios Pharmaceuticals's investors include ARCH Venture Partners, Third Rock Ventures, Flagship Pioneering, LLC, Flagship Ventures and Celgene.
Agios Pharmaceuticals has raised $120M across 4 rounds since 2008. One round did not disclose an amount, so the total is a floor.
Agios Pharmaceuticals's most recent round was a Series C of $78M in Nov 2011.
Its most recent round, $78M in Nov 2011, is also its largest on record.
Agios Pharmaceuticals's first round on record, in Jul 2008, was backed by ARCH Venture Partners, Third Rock Ventures and Flagship Ventures.
Agios Pharmaceuticals's latest named round is a Series C, in Nov 2011.
Agios Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.